Viactiv® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022

Author:

Guardion Health Sciences, Inc. has released its financial results for the year ended December 31, 2023. The company reported total revenue of $12,248,550 for the year, representing a 10.8% increase compared to the previous year. The Viactiv® product line, which accounted for the majority of the company’s revenue, generated net revenues of $11,907,867, an increase of 11.9%.

The increase in revenue was attributed to the strong sales performance of the Viactiv® product line. Gross profit for the year was $5,394,517, a 19.3% increase from the previous year. This increase in gross profit was driven by higher sales from the Viactiv® product line and a higher gross margin of 44.0%.

Total operating expenses for the year decreased to $9,730,834, compared to $21,940,985 in the previous year. This decrease was primarily due to the write-off of intangible assets, lower executive stock compensation expense, and lower consultant fees.

As a result, the company reported a net income of $158,033 for the year, a significant improvement from the net loss of $(14,922,228) in the previous year. The company’s cash flow also improved, with cash used in operations decreasing by $3,076,927.

In addition, the company announced a recent development in 2024. They have entered into an agreement to sell Activ Nutritional, LLC, the owner of the Viactiv® brand, to Doctor’s Best Inc. for $17.2 million. This sale is subject to approval from the company’s stockholders and, if approved, would result in minimal operations for the company. The company’s board of directors has also proposed a voluntary dissolution and liquidation of the company, pending stockholder approval.

Overall, Guardion Health Sciences reported positive financial results for the year ended December 31, 2023, driven by the strong performance of the Viactiv® product line.

Guardion Health Sciences, Inc. operates in the healthcare industry, specifically in the field of nutritional supplements. The company’s flagship product line, Viactiv®, focuses on providing essential vitamins and minerals to support overall health and wellness. Viactiv® is a well-known brand in the nutritional supplement market and has gained popularity among consumers.

Market forecasts for the nutritional supplement industry indicate steady growth in the coming years. The increasing interest in preventive healthcare and the growing aging population are driving the demand for nutritional supplements. Consumers are becoming more conscious of their health and are seeking products that can support their well-being. This trend presents a favorable market environment for companies like Guardion Health Sciences that offer innovative and high-quality nutritional supplements.

However, the industry also faces challenges and issues. One of the main challenges is ensuring product safety and efficacy. With a wide variety of nutritional supplements available in the market, it is crucial for companies to maintain strict quality control measures and adhere to regulatory standards. Guardion Health Sciences has built a strong reputation for quality and safety, which has contributed to the success of their Viactiv® product line.

To stay competitive and meet consumer demands, companies in the nutritional supplement industry need to constantly innovate and develop new products. Research and development play a vital role in creating effective and differentiated products that can address specific health needs. Guardion Health Sciences has demonstrated its commitment to product innovation through the success of the Viactiv® product line.

For further information on the nutritional supplement industry and market trends, you can visit Nutraceuticals World, a comprehensive source of industry news and insights. Additionally, PubMed provides access to scientific studies and research related to nutritional supplements and their efficacy.

In conclusion, Guardion Health Sciences has achieved positive financial results for the year, primarily driven by the strong performance of their Viactiv® product line. The company operates in the growing nutritional supplement industry, which presents opportunities for growth and expansion. As the industry continues to evolve, companies need to focus on product quality, innovation, and meeting consumer demands to maintain their competitive edge.